- $1.90bn
- $1.69bn
- $249.60m
LeMaitre Vascular Inc reports results for the quarter ended June 30 - Earnings Summary
LeMaitre Vascular Q2 sales slightly miss estimates
Brief: LeMaitre Vascular Q2 Sales USD 70.382 Million Vs. IBES Estimate USD 71 Million
LeMaitre Vascular Q1 sales slightly beat estimates on product growth
Brief: LeMaitre Vascular Q1 Sales USD 66.551 Million Vs. IBES Estimate USD 66.5 Million
LeMaitre Vascular beat Q4 sales expectations, raises dividend
Brief: LeMaitre Vascular Q4 Sales USD 64.453 Million Vs. IBES Estimate USD 62.8 Million
Vascular surgical devices provider LeMaitre Q3 sales miss estimates
Brief: LeMaitre Vascular Q3 Sales USD 61.046 Million Vs. IBES Estimate USD 62.2 Million
LeMaitre Vascular Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: LeMaitre Vascular Q2 Sales USD 64.232 Million Vs. IBES Estimate USD 62.5 Million
LeMaitre Vascular Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: LeMaitre Vascular Q1 Sales USD 59.871 Million Vs. IBES Estimate USD 57.6 Million
LeMaitre Vascular Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: LeMaitre Vascular Q4 Sales USD 55.717 Million Vs. IBES Estimate USD 56 Million
U.S. STOCKS ON THE MOVE-Tesla, Hyatt Hotels, General Dynamics
Wells Fargo initiates coverage on LeMaitre Vascular with 'equal weight' rating
Brief: Lemaitre Vascular Prices $150 Million Convertible Senior Notes
U.S. STOCKS ON THE MOVE-Teradyne, Keysight Technologies, Ametek